|
OMIM |
Link |
Information gain |
01 |
|
danubian endemic familial nephropathy
|
[NCBI]
|
0.00153915
|
|
|
TINU
|
[NCBI]
|
0.00134039
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00125196
|
|
|
cranioectodermal dysplasia
|
[NCBI]
|
0.000764597
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000697531
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
0.000240764
|
|
|
SPP1
|
[NCBI]
|
0.000225333
|
|
|
nephropathy, progressive tubulointerstitial, with cholestatic liver disease
|
[NCBI]
|
0.000120229
|
|
|
HNFJ
|
[NCBI]
|
0.000117762
|
|
|
NPHP1
|
[NCBI]
|
0.000113248
|
|
|
CTGF
|
[NCBI]
|
0.000105354
|
|
|
TINAG
|
[NCBI]
|
8.01986e-05
|
|
|
LR8
|
[NCBI]
|
8.01986e-05
|
|
|
NPHP2
|
[NCBI]
|
6.94132e-05
|
|
|
hepatocellular carcinoma-associated antigen 112
|
[NCBI]
|
6.64209e-05
|
|
|
KLF15
|
[NCBI]
|
6.64209e-05
|
|
|
SLSN1
|
[NCBI]
|
5.37602e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
5.23988e-05
|
|
|
CBP2
|
[NCBI]
|
5.02572e-05
|
|
|
SMAD3
|
[NCBI]
|
4.90145e-05
|
|
|
INVS
|
[NCBI]
|
4.69181e-05
|
|
|
PHB
|
[NCBI]
|
4.60162e-05
|
|
|
ACE
|
[NCBI]
|
4.36747e-05
|
|
|
UMOD
|
[NCBI]
|
3.43437e-05
|
|
|
B2M
|
[NCBI]
|
3.03274e-05
|
|
|
SLC4A1
|
[NCBI]
|
2.99878e-05
|
|
|
MCP
|
[NCBI]
|
2.68822e-05
|
|
|
APRT
|
[NCBI]
|
2.18756e-05
|
|
|
MPO
|
[NCBI]
|
2.05947e-05
|
|
|
PCNA
|
[NCBI]
|
1.71308e-05
|
|
|
CVID
|
[NCBI]
|
1.27179e-05
|
|
|
ALB
|
[NCBI]
|
1.25312e-05
|
|
|
XDH
|
[NCBI]
|
1.1749e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.12825e-05
|
|
|
PTH
|
[NCBI]
|
9.48056e-06
|
|
|
RA
|
[NCBI]
|
7.79219e-06
|
|
|
SLE
|
[NCBI]
|
3.02919e-06
|
|
|
HGF
|
[NCBI]
|
2.1144e-06
|
|
|
EGF
|
[NCBI]
|
5.20523e-07
|
|
|
EPO
|
[NCBI]
|
5.05539e-07
|
|
|
VEGF
|
[NCBI]
|
4.27613e-07
|
|
|
TNF
|
[NCBI]
|
6.91416e-08
|
|